University of Hertfordshire

From the same journal

By the same authors

The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer

Research output: Contribution to journalArticlepeer-review

Standard

The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. / Omorphos, Nicolas Pavlos; Ghose, Aruni; Hayes, John; Kandala, Abhinav; Dasgupta, Prokar; Sharma, Anand; Vasdev, Nikhil.

In: Urologic Oncology, 14.05.2022.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Omorphos, N. P., Ghose, A., Hayes, J., Kandala, A., Dasgupta, P., Sharma, A., & Vasdev, N. (Accepted/In press). The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. Urologic Oncology.

Vancouver

Omorphos NP, Ghose A, Hayes J, Kandala A, Dasgupta P, Sharma A et al. The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. Urologic Oncology. 2022 May 14.

Author

Omorphos, Nicolas Pavlos ; Ghose, Aruni ; Hayes, John ; Kandala, Abhinav ; Dasgupta, Prokar ; Sharma, Anand ; Vasdev, Nikhil. / The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. In: Urologic Oncology. 2022.

Bibtex

@article{54363d63dba1481abab0e4958aef64aa,
title = "The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer",
abstract = "Context: The management of locally advanced Muscle Invasive Bladder Cancer (MIBC) often necessitates neo-adjuvant chemotherapy (NAC) to eliminate any micro-metastatic disease prior to definitive radical cystectomy (RC) and pelvic lymph node dissection (PLND). The use of new imaging techniques, such as FDG-PET/CT, enables more accurate initial staging of bladder cancer. In addition, it appears to be better at assessing cancer response to NAC, compared to the more traditional CT and MRI imaging, which is crucial for definitive peri-operative surgical planning.Objective: Review the evolving indications of functional F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in MIBC.Conclusion: FDG-PET/CT is being increasingly utilised in local nodal staging and detection of metastatic disease in MIBC. Furthermore, it appears more accurate than conventional imaging modalities (CT/MRI) in assessing tumour response to NAC. This enables the earlier detection of tumour response and/or residual disease, impacting factors such as the duration of chemotherapy, with its associated adverse effects, and the timing of surgical intervention",
author = "Omorphos, {Nicolas Pavlos} and Aruni Ghose and John Hayes and Abhinav Kandala and Prokar Dasgupta and Anand Sharma and Nikhil Vasdev",
year = "2022",
month = may,
day = "14",
language = "English",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer

AU - Omorphos, Nicolas Pavlos

AU - Ghose, Aruni

AU - Hayes, John

AU - Kandala, Abhinav

AU - Dasgupta, Prokar

AU - Sharma, Anand

AU - Vasdev, Nikhil

PY - 2022/5/14

Y1 - 2022/5/14

N2 - Context: The management of locally advanced Muscle Invasive Bladder Cancer (MIBC) often necessitates neo-adjuvant chemotherapy (NAC) to eliminate any micro-metastatic disease prior to definitive radical cystectomy (RC) and pelvic lymph node dissection (PLND). The use of new imaging techniques, such as FDG-PET/CT, enables more accurate initial staging of bladder cancer. In addition, it appears to be better at assessing cancer response to NAC, compared to the more traditional CT and MRI imaging, which is crucial for definitive peri-operative surgical planning.Objective: Review the evolving indications of functional F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in MIBC.Conclusion: FDG-PET/CT is being increasingly utilised in local nodal staging and detection of metastatic disease in MIBC. Furthermore, it appears more accurate than conventional imaging modalities (CT/MRI) in assessing tumour response to NAC. This enables the earlier detection of tumour response and/or residual disease, impacting factors such as the duration of chemotherapy, with its associated adverse effects, and the timing of surgical intervention

AB - Context: The management of locally advanced Muscle Invasive Bladder Cancer (MIBC) often necessitates neo-adjuvant chemotherapy (NAC) to eliminate any micro-metastatic disease prior to definitive radical cystectomy (RC) and pelvic lymph node dissection (PLND). The use of new imaging techniques, such as FDG-PET/CT, enables more accurate initial staging of bladder cancer. In addition, it appears to be better at assessing cancer response to NAC, compared to the more traditional CT and MRI imaging, which is crucial for definitive peri-operative surgical planning.Objective: Review the evolving indications of functional F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in MIBC.Conclusion: FDG-PET/CT is being increasingly utilised in local nodal staging and detection of metastatic disease in MIBC. Furthermore, it appears more accurate than conventional imaging modalities (CT/MRI) in assessing tumour response to NAC. This enables the earlier detection of tumour response and/or residual disease, impacting factors such as the duration of chemotherapy, with its associated adverse effects, and the timing of surgical intervention

M3 - Article

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

ER -